Paul Steinke
Foot & Ankle Surgery · Grapevine, TXNPI 1578709648
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $193,587 of the $232,582 with a category attached, or 83.2%. Treace Medical Concepts, Inc. accounts for 98.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $66,975 and has fallen 67.3% since, to $21,890 in 2025. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $698.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$230K
- Pylant Medical$1K
- Stryker$552
- Amgen$273
- AbbVie$152
- Fusion Orthopedics USA, LLC$150
- plus $783 from 16 others
Across 89 payments — averaging $1397.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Treace Medical Concepts, Inc.$96K
- Smith+Nephew$28K
What the payments were for
- Consulting fees$193,58783%
- Speaking & faculty fees$120%
- Travel & lodging$27,14312%
- Food & beverage$10,7245%
- Education$1,1150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 268 | $229,525 |
| Pylant Medical | 3 | $1,145 |
| Stryker(2 entities) | 5 | $552 |
| Amgen(2 entities) | 10 | $273 |
| AbbVie | 7 | $152 |
| Fusion Orthopedics USA, LLC | 1 | $150 |
| Smith+Nephew | 6 | $149 |
| Orthofix Medical, Inc. | 7 | $136 |
| Bioventus LLC | 3 | $76 |
| Organogenesis Inc. | 3 | $59 |
| Johnson & Johnson | 2 | $54 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Medtronic | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Nevro Corp. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Biowound Solutions, Inc. | 3 | $25 |
| Innovation Technologies Inc | 1 | $24 |
| Mimedx Group, Inc. | 1 | $23 |
| Curonix LLC | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$201,781
- LAPIPLASTY SYSTEM 1$17,883
- Lapiplasty$3,636
- TMC NANOPLASTY SYSTEM$945
- HOFFMANN$334
- TMC SPEEDMTP$221
- SONICANCHOR$165
- TMC SPEEDTMT$142
How this compares
$232,582 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $429 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $269 |
| Doxycycline Hyclate | 30 | $237 |
| Mupirocin | 12 | $92 |
| Gabapentin | 27 | $63 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Grapevine
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.